Literature DB >> 21382250

Phaeochromocytoma in black South Africans - a 30-year audit.

K R L Huddle1.   

Abstract

OBJECTIVE: Phaeochromocytomas are catecholamine-secreting tumours, the majority of which arise from the adrenal medulla. Untreated, they are potentially lethal; early diagnosis and treatment offer a good chance of cure. They are rarely reported in blacks. The clinical presentation and outcome of phaeochromocytoma in a large cohort of black South Africans is reviewed.
METHODS: Patients' records in a tertiary care university hospital were reviewed. Fifty-four black patients presenting with phaeochromocytoma between 1980 and 2009 were included. The clinical presenting features, tumour localisation and outcome were assessed.
RESULTS: Fifty-four (41 female, 13 male; age range 8 - 57 years) patients were identified. Five (9%) had familial syndromes; 49 (91%) were deemed sporadic. All tumours were intra-abdominal: 34 (61%) were adrenal and 22 (39%) extra-adrenal in origin. The most common symptoms were headache (77%), palpitations (77%), and sweating (74%). All were hypertensive, almost equally divided between paroxysmal and sustained hypertension. Six (11%) presented in congestive cardiac failure including 2 with catecholamine-induced myocarditis. Two patients had features which simulated hypertrophic obstructive cardiomyopathy. Nine women presented in pregnancy: there was no maternal mortality; fetal mortality included 1 early neonatal death and 1 intrauterine death. There were 4 deaths: 1 from postoperative haemorrhage, 1 from multisystem crisis, 1 from metastatic medullary thyroid carcinoma, and 1 from catecholamine-induced myocarditis.
CONCLUSION: Phaeochromocytoma is an important although rare tumour in blacks, with similar clinical presentations and complications to those in white patients. Timely diagnosis and appropriate treatment resulted in a favourable outcome in over 90% of patients in this study.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21382250     DOI: 10.7196/samj.4320

Source DB:  PubMed          Journal:  S Afr Med J


  6 in total

1.  Surgery for Pheochromocytoma: A Single-Center Review of 60 Cases from South Africa.

Authors:  D Nel; E Panieri; F Malherbe; R Steyn; L Cairncross
Journal:  World J Surg       Date:  2020-06       Impact factor: 3.352

2.  Phaeochromocytoma in a 20-year-old Nigerian, resolving the dilemma of benignity or malignancy.

Authors:  Fred O Ugwumba; Okechukwu C Okafor; Agharighom David Okoh; Obinna Virginus Ajuzieogu
Journal:  Clin Pract       Date:  2012-01-18

3.  Dutch founder SDHB exon 3 deletion in patients with pheochromocytoma-paraganglioma in South Africa.

Authors:  Debra M Gordon; Pablo Beckers; Emilie Castermans; Sebastian J C M M Neggers; Liliya Rostomyan; Vincent Bours; Patrick Petrossians; Vinciane Dideberg; Albert Beckers; Adrian F Daly
Journal:  Endocr Connect       Date:  2022-01-31       Impact factor: 3.335

4.  A Study of Paraganglioma Cases With Non-European Ancestry.

Authors:  Sadia Ejaz; Neeharika Nandam; Susan Maygarden; Maya Styner
Journal:  Cureus       Date:  2022-08-10

5.  Maternal and fetal outcomes in phaeochromocytoma and pregnancy: a multicentre retrospective cohort study and systematic review of literature.

Authors:  Irina Bancos; Elizabeth Atkinson; Charis Eng; William F Young; Hartmut P H Neumann
Journal:  Lancet Diabetes Endocrinol       Date:  2020-11-26       Impact factor: 32.069

6.  Secondary hypertension: An update on the diagnosis and localisation of a pheochromocytoma or paraganglioma.

Authors:  Nida Siddiqui; Reyna Daya; Faheem Seedat; Saajidah Bulbulia; Zaheer Bayat
Journal:  S Afr Fam Pract (2004)       Date:  2021-07-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.